Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood.


The use of umbilical cord blood as a source of marrow repopulating cells for the treatment of pediatric malignancies has been established. Given the general availability, the ease of procurement, and progenitor content, cord blood is an attractive alternative to bone marrow or growth factor mobilized peripheral blood cells as a source of transplantable… (More)

5 Figures and Tables


  • Presentations referencing similar topics